di Reumatologia, Società Italiana, trans. 2025. “PO:36:243 | Drug Survival, Discontinuation Reasons and Disease Activity in Patients With Behçet’s Disease Treated With Infliximab - a Real-Life Study: Antonello Sulis1, Federica Di Cianni1, Maria Laura Manca2, Rosaria Talarico1, Marta Mosca1. | 1Rheumatology Unit of Pisa, University of Pisa, Pisa, Italy, Pisa, Italy; 2Department of Clinical and Experimental Medicine and Department of Mathematics, University of Pisa, Italy, Pisa, Italy”. Reumatismo 77 (s1). https://doi.org/10.4081/reumatismo.2025.2091.